These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 10487609

  • 1. Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer.
    Blok LJ, Chang GT, Steenbeek-Slotboom M, van Weerden WM, Swarts HG, De Pont JJ, van Steenbrugge GJ, Brinkmann AO.
    Br J Cancer; 1999 Sep; 81(1):28-36. PubMed ID: 10487609
    [Abstract] [Full Text] [Related]

  • 2. Differentially expressed genes in androgen-dependent and -independent prostate carcinomas.
    Chang GT, Blok LJ, Steenbeek M, Veldscholte J, van Weerden WM, van Steenbrugge GJ, Brinkmann AO.
    Cancer Res; 1997 Sep 15; 57(18):4075-81. PubMed ID: 9307296
    [Abstract] [Full Text] [Related]

  • 3. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer.
    Chang GT, Jhamai M, van Weerden WM, Jenster G, Brinkmann AO.
    Endocr Relat Cancer; 2004 Dec 15; 11(4):815-22. PubMed ID: 15613454
    [Abstract] [Full Text] [Related]

  • 4. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL, McBride WH, Sun J, Patel B, Tsui KH, Paik SH, Gitlitz B, Caliliw R, van Ophoven A, Wu L, deKernion J, Belldegrun A.
    Cancer J; 2000 Dec 15; 6(4):220-33. PubMed ID: 11038142
    [Abstract] [Full Text] [Related]

  • 5. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells.
    Schatten H, Ripple M, Balczon R, Weindruch R, Chakrabarti A, Taylor M, Hueser CN.
    J Cell Biochem; 2000 Jan 15; 76(3):463-77. PubMed ID: 10649443
    [Abstract] [Full Text] [Related]

  • 6. Evolution of the androgen receptor pathway during progression of prostate cancer.
    Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J, Jenster G.
    Cancer Res; 2006 May 15; 66(10):5012-20. PubMed ID: 16707422
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
    Fujinami K, Uemura H, Ishiguro H, Kubota Y.
    Int J Mol Med; 2002 Aug 15; 10(2):173-6. PubMed ID: 12119554
    [Abstract] [Full Text] [Related]

  • 10. Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response.
    Soto AM, Lin TM, Sakabe K, Olea N, Damassa DA, Sonnenschein C.
    Oncol Res; 1995 Aug 15; 7(10-11):545-58. PubMed ID: 8866667
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Androgen blocks apoptosis of hormone-dependent prostate cancer cells.
    Kimura K, Markowski M, Bowen C, Gelmann EP.
    Cancer Res; 2001 Jul 15; 61(14):5611-8. PubMed ID: 11454715
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A, Fraizer GC, Piantanelli L, Saunders GF.
    Anticancer Res; 2001 Jul 15; 21(1A):1-10. PubMed ID: 11299720
    [Abstract] [Full Text] [Related]

  • 14. Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling.
    Oosterhoff JK, Grootegoed JA, Blok LJ.
    Endocr Relat Cancer; 2005 Mar 15; 12(1):135-48. PubMed ID: 15788645
    [Abstract] [Full Text] [Related]

  • 15. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells.
    Robbins SE, Shu WP, Kirschenbaum A, Levine AC, Miniati DN, Liu BC.
    Prostate; 1996 Dec 15; 29(6):362-70. PubMed ID: 8977633
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.
    Zha S, Ferdinandusse S, Denis S, Wanders RJ, Ewing CM, Luo J, De Marzo AM, Isaacs WB.
    Cancer Res; 2003 Nov 01; 63(21):7365-76. PubMed ID: 14612535
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regulation of S100P expression by androgen.
    Averboukh L, Liang P, Kantoff PW, Pardee AB.
    Prostate; 1996 Dec 01; 29(6):350-5. PubMed ID: 8977631
    [Abstract] [Full Text] [Related]

  • 20. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
    Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, Abrahamsson PA, Taskén KA.
    Prostate; 2008 Jul 01; 68(10):1133-42. PubMed ID: 18454446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.